Detalhe da pesquisa
1.
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.
Haematologica
; 108(5): 1272-1283, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700399
2.
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients.
Cancer Rep (Hoboken)
; 6(12): e1901, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933765
3.
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
J Immunother Cancer
; 11(11)2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007238
4.
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.
Cell Rep Med
; 4(11): 101290, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992684